542.71
전일 마감가:
$542.65
열려 있는:
$541.48
하루 거래량:
380.13K
Relative Volume:
0.50
시가총액:
$42.30B
수익:
$3.93B
순이익/손실:
$894.97M
주가수익비율:
50.16
EPS:
10.82
순현금흐름:
$837.70M
1주 성능:
+2.32%
1개월 성능:
+5.42%
6개월 성능:
+32.74%
1년 성능:
+13.72%
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-02 | 개시 | Leerink Partners | Outperform |
2024-07-25 | 개시 | BTIG Research | Buy |
2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
2022-07-12 | 개시 | Piper Sandler | Overweight |
2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-02-08 | 개시 | Atlantic Equities | Overweight |
2021-11-18 | 개시 | Morgan Stanley | Overweight |
2021-08-05 | 재개 | Credit Suisse | Outperform |
2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
2021-02-17 | 개시 | Barclays | Overweight |
2019-09-09 | 개시 | Goldman | Neutral |
2019-05-23 | 개시 | Guggenheim | Buy |
2018-11-02 | 재확인 | BofA/Merrill | Buy |
2018-05-07 | 재확인 | Stifel | Buy |
2018-01-16 | 개시 | Piper Jaffray | Overweight |
2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
2016-09-29 | 재개 | BofA/Merrill | Neutral |
2016-08-16 | 재확인 | Stifel | Buy |
2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
2016-07-20 | 재확인 | Canaccord Genuity | Buy |
2016-04-19 | 재확인 | Canaccord Genuity | Buy |
2016-04-01 | 개시 | CL King | Neutral |
2016-03-21 | 재확인 | Stifel | Buy |
2016-02-04 | 개시 | Credit Suisse | Outperform |
2015-10-29 | 재확인 | Stifel | Buy |
2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2015-08-13 | 재확인 | Stifel | Buy |
2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey
12 Best Healthcare Stocks to Buy Now - Insider Monkey
IDEXX Laboratories Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
IDEXX Laboratories (IDXX) Sees Price Target Raised by Leerink Pa - GuruFocus
Three Lawmakers Bought This Biotech Stock Before Supporting A Bill That Could Boost Its Value: It's Now Up 44% - Benzinga
Is IDEXX Laboratories Stock Outperforming The Dow? - Barchart.com
Is IDEXX Laboratories Stock Outperforming the Dow? - The Globe and Mail
Leerink Partners Adjusts IDEXX Laboratories Price Target to $580 From $515 - MarketScreener
Kalkine : IDEXX Laboratories Performance Within S&P 500 Index Framework - Kalkine Media
IDEXX Labs $IDXX Sees Surge in Political Buys: 3 Politicians on Agriculture Committees Invest – Crypto Market Eyes Regulatory Impact - Blockchain News
IDEXX Catalyst Cortisol Rapid Canine Dx - Precedence Research
Amazon Delivery Robots Could Haunt Your Front Porch - Yahoo! Autos
Jim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can’t Get My Arms Around It” - MSN
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders - StreetInsider
IDEXX Unveils Game-Changing Dog Disease Test: Breakthrough for Detecting Life-Threatening Addison's Disease - Stock Titan
IDEXX Laboratories (IDXX) Stock Analysis: A Look at Its Robust 59.33% ROE Amidst Market Challenges - DirectorsTalk Interviews
Jim Cramer’s Thoughts on These 10 Stocks - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Stock Rating Lowered by Wall Street Zen - Defense World
Companion Animal Diagnostics Market Is Booming WorldwideIDEXX Laboratories, Heska Corporation - openPR.com
Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10 - marketscreener.com
IDEXX Laboratories To Present At Stifel Jaws & Paws Conference; Webcast At 10:55 AM ET - Nasdaq
IDEXX Laboratories Stock: Analyst Estimates & Ratings - MSN
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
IDEXX Lab jumps after Q1 beat and guidance raise - MSN
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Benzinga
IDEXX Laboratories (NASDAQ:IDXX) Given New $510.00 Price Target at Stifel Nicolaus - Defense World
IDEXX Laboratories (IDXX) Target Price Raised by Stifel to $510 | IDXX Stock News - GuruFocus
If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Idexx Laboratories (IDXX) Price Target Increased by Stifel Analy - GuruFocus
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $460, Maintains Hold Rating - marketscreener.com
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits (NASDAQ:IDXX) - Seeking Alpha
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Director Cashes In: Idexx Laboratories Stock Sale Revealed - TipRanks
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day | IDXX Stock News - GuruFocus
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day - Business Wire
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $577 From $566, Maintains Outperform Rating - marketscreener.com
IDEXX Laboratories (NASDAQ:IDXX) Upgraded at StockNews.com - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable - simplywall.st
Idexx outlines 2025 growth with 6-9% organic revenue target amid innovation launches - MSN
IDEXX Laboratories (IDXX) Announces Key Amendments to Corporate Structure - GuruFocus
IDEXX Laboratories Updates Corporate Governance Structure - TipRanks
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $558.00 at Morgan Stanley - Defense World
Rep. April McClain Delaney Buys IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - Defense World
IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이덱스 래버러토리스 주식 (IDXX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
SZOSTAK M ANNE | Director |
May 21 '25 |
Option Exercise |
160.28 |
1,046 |
167,653 |
1,308 |
SZOSTAK M ANNE | Director |
May 21 '25 |
Sale |
512.34 |
1,260 |
645,545 |
1,801 |
SZOSTAK M ANNE | Director |
May 21 '25 |
Sale |
513.74 |
1,046 |
537,372 |
262 |
자본화:
|
볼륨(24시간):